Interview with Braizon Therapeutics

Applying intelligently glycemic control and a systematic route through the BBB (blood-brain barrier) to effectively reach neurons. Venture Valuation (VV) interviewed the CEO, Mariko Tosu, PhD

Read more

Interviews with leading Life Sciences companies: Ava AG

Inspired by co-founder Lea von Bidder’s concept, the Ava bracelet is becoming an indispensable device for women to monitor their own biological rhythms. Venture Valuation (VV) interviewed Vicky Kummer, Global Brand Manager. Read the interview Would you like to be notified about new interviews, reports and other valuable content published by Venture Valuation?

Read more

Interviews with leading Life Sciences companies: Innophys Co.

Invented by Prof. Hiroshi Kobayashi, Department of Mechanical Engineering, Tokyo University of Science, the Muscle Suit® is becoming an indispensable device for the elderly care services as well as many other heavy lifting tasks. Venture Valuation (VV) interviewed Takashi Furukawa, CEO. Read the interview Would you like to be notified about new reports and other … Continue reading Interviews with leading Life Sciences companies: Innophys Co.

Read more

Interviews with leading Life Sciences companies: tella inc.

Leveraging its proprietary technology of culturing highly purified dendritic cells (DCs), tella is developing, as its first immunotherapeutic product, a DC-based vaccine in combination with WT1 (Wilms’ tumor gene 1) antigen for inoperable pancreatic cancer. Venture Valuation (VV) interviewed Dr. Yuichiro Yazaki, President and CEO. Read the interview

Read more

Interviews with leading Life Sciences companies: Cellestia Biotech AG

Created by two scientists at the École Politechnique Fédérale de Lausanne (EPFL) in 2014 and joined by experienced drug development and business professionals in 2015, Cellestia Biotech AG is developing oral medication along with companion diagnostics for Notch dependent hematological malignancies and solid tumors. Venture Valuation (VV) interviewed the CEO, Dr. Michael Bauer in Basel, … Continue reading Interviews with leading Life Sciences companies: Cellestia Biotech AG

Read more